Theon Pharmaceuticals Limited Sustainability Profile
Theon Pharmaceuticals Limited, a prominent player in the pharmaceutical industry, is headquartered in India and operates extensively across various regions. Founded in 2005, the company has established itself as a leader in the development and manufacturing of high-quality injectable pharmaceuticals, particularly in the areas of oncology and anaesthesia. Theon Pharmaceuticals is renowned for its commitment to innovation, offering a diverse portfolio of products that meet stringent regulatory standards. Their unique formulations and advanced delivery systems set them apart in a competitive market. With a strong focus on research and development, Theon has achieved significant milestones, including numerous product approvals and partnerships that enhance its market position. As a trusted name in the pharmaceutical sector, Theon Pharmaceuticals continues to contribute to global healthcare advancements.
DitchCarbon Score
How does Theon Pharmaceuticals Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Theon Pharmaceuticals Limited's score of 14 is lower than 91% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Theon Pharmaceuticals Limited's reported carbon emissions
Theon Pharmaceuticals Limited, headquartered in India, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Theon Pharmaceuticals may not have established formal commitments to reduce its carbon footprint or engage in climate initiatives at this time. In the context of the pharmaceutical industry, many companies are increasingly focusing on sustainability and carbon reduction strategies. However, without specific emissions data or commitments, it is challenging to assess Theon Pharmaceuticals' position relative to industry standards.
How Carbon Intensive is Theon Pharmaceuticals Limited's Industry?
How Carbon Intensive is Theon Pharmaceuticals Limited's Location?
Theon Pharmaceuticals Limited's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Theon Pharmaceuticals Limited has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
